In light of the significant role of the BM in tumor progression, our study introduces MMP14 as a pivotal hub gene within the BMRGs cluster impacting BLCA prognosis and response to immunotherapy. The gene discussed is MMP14; the disease is bladder transitional cell carcinoma.